HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis

BACKGROUND: Bruton’s tyrosine kinase (Btk) is critical for activation of B cells and myeloid cells. This study aimed to characterize the effects of HM71224, a novel Btk inhibitor, both in vitro and in a mouse model of experimental arthritis. METHODS: The kinase inhibition profile of HM71224 was anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jin Kyun, Byun, Joo-Yun, Park, Ji Ah, Kim, Yu-Yon, Lee, Ye Ji, Oh, Jeong In, Jang, Sun Young, Kim, Young Hoon, Song, Yeong Wook, Son, Jeewoong, Suh, Kwee Hyun, Lee, Young-Mi, Lee, Eun Bong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835877/
https://www.ncbi.nlm.nih.gov/pubmed/27090981
http://dx.doi.org/10.1186/s13075-016-0988-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835877/
https://www.ncbi.nlm.nih.gov/pubmed/27090981
http://dx.doi.org/10.1186/s13075-016-0988-z

Ejemplares similares